Literature DB >> 10851263

Molecular genetic alterations and viral presence in ophthalmic pterygium.

E T Detorakis1, E E Drakonaki, D A Spandidos.   

Abstract

Pterygium is a lesion of the corneoscleral limbus which tends to grow in size, often recurs after surgical excision and is associated with exposure to solar light. Additionally, a family history is frequently reported. Loss of heterozygosity (LOH), increased P53 expression and the presence of oncogenic viruses, such as human papilloma virus (HPV) and herpes simplex virus (HSV), have been detected in pterygia, supporting the possible neoplastic nature of the lesion. Co-infection by HSV and HPV as well as LOH at some loci have also been correlated with clinical features, such as postoperative recurrence and history of conjunctivitis. A possible model of pterygium formation is proposed, in which genetic predisposition, environmental factors and viral infection(s) participate in a multi-step process. Future research may lead to new ways of pterygium treatment such as anti-viral or gene therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851263

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  25 in total

1.  Detection of human papillomavirus DNA in pterygia from different geographical regions.

Authors:  F Piras; P S Moore; J Ugalde; M T Perra; A Scarpa; P Sirigu
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

2.  Lack of human papillomavirus in pterygium of Chinese patients from Taiwan.

Authors:  K-H Chen; W-M Hsu; C-C Cheng; Y-S Li
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

3.  No association of p53 codon 72 and p21 codon 31 polymorphisms in Taiwan Chinese patients with pterygium.

Authors:  Y Y Tsai; Y Y Tsai; Y W Cheng; H Lee; S H Tseng; C H Tsai; F J Tsai
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

4.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

5.  Identification and differentiation therapy strategy of pterygium in vitro.

Authors:  Xinyuan Hu; Nitin Tandra; Zhijian Zhang; Aihua Gong; Jingyan Chen; Yang Li; Qian Chen; Wenrong Xu; Hui Qian
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

6.  The expression of vascular endothelial growth factor in pterygium tissue of atopic patients.

Authors:  Hamid Gharaee; Mohammad Reza Shayegan; Mohammad Reza Khakzad; Sina Kianoush; A-Reza Varasteh; Mojtaba Sankian; Mojtaba Meshkat
Journal:  Int Ophthalmol       Date:  2014-10-26       Impact factor: 2.031

7.  Non-invasive detection of HPV DNA in exfoliative samples from ophthalmic pterygium: a feasibility study.

Authors:  Αikaterini K Chalkia; Stavros Derdas; Georgios Bontzos; George Sourvinos; Εfstathios T Detorakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-09       Impact factor: 3.117

Review 8.  Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia.

Authors:  N Di Girolamo
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

9.  Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.

Authors:  Chun-Chi Chiang; Yi-Yu Tsai; Da-Tian Bau; Ya-Wen Cheng; Sung-Huei Tseng; Rou-Fen Wang; Fuu-Jen Tsai
Journal:  Mol Vis       Date:  2010-04-20       Impact factor: 2.367

10.  XRCC1, but not APE1 and hOGG1 gene polymorphisms is a risk factor for pterygium.

Authors:  Pei-Liang Chen; Kun-Tu Yeh; Yi-Yu Tsai; Hank Koeh; Yu-Ling Liu; Huei Lee; Ya-Wen Cheng
Journal:  Mol Vis       Date:  2010-06-04       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.